Epidemiology and outcome of cervical cancer in national institute of Morocco
Open Access
- 13 September 2016
- journal article
- research article
- Published by Springer Nature in BMC Women's Health
- Vol. 16 (1) , 62
Abstract
On behalf of the medical staff of the National Institute of Oncology of Rabat, we conducted a retrospective study to report epidemiology and 5-year outcomes of cervical carcinoma in Moroccan women. We reviewed all women diagnosed with invasive cervical carcinoma in our institute between January 2006 and December 2006. Outcomes and prognoses are analyzed in patients who received at least one treatment. The analysis included 646 women. Median age was 50 years (23–85 years). Bleeding was the most frequent symptom (95 %). The most predominant histology was squamous cell carcinoma (94 %). The majority of patients were diagnosed at locally advanced stages (88 %). Among patients who received treatment (n = 550), the management was based on concurrent chemoradiotherapy in 69.7 % of cases. The median duration of follow-up was 60 months (range 2–78 months). Overall survival, progression free survival, and locoregional recurrence free survival were 63.2, 60.7 and 79.1 % respectively. Significant poor prognostic factors in univariate analysis included stage, tumor size, lymph node involvement, anemia and absence of response to radiotherapy. The prognostic significance of response to radiotherapy and stage were retained in multivariate analysis. Cervical cancer in our Institute is diagnosed at locally advanced stages. Two third of patients were treated by concurrent chemoradiotherapy. Outcome of Moroccan patients are comparable to that of western countries. Significant prognostic factors were stage, tumor size, lymph node involvement, anemia, and response to radiotherapy. The way to reduce the global burden of cervical cancer in our country continues to be the development of vaccination and screening programs.Keywords
This publication has 18 references indexed in Scilit:
- Epidemiologic characteristics of cervical cancer in Korean womenJournal of Gynecologic Oncology, 2014
- Analysis of Factors Contributing to the Low Survival of Cervical Cancer Patients Undergoing Radiotherapy in KenyaPLOS ONE, 2013
- A Population-based Study of Cervix Cancer: Incidence, Management and Outcome in the Canadian Province of SaskatchewanClinical Oncology, 2011
- Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysisRadiotherapy and Oncology, 1995
- Youth as a prognostic factor in carcinoma of the cervix: A matched analysisGynecologic Oncology, 1992
- Screening as a prognostic factor in cervical cancer: Analysis of survival and prognostic factors based on Icelandic population data, 1964–1988Gynecologic Oncology, 1991
- Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- Young age as a prognostic factor in cervical cancer: analysis of population based data from 10 022 casesBMJ, 1988
- Survival, prognostic factors, and relapse patterns in uterine cervical carcinomaAmerican Journal of Clinical Oncology, 1983
- Pretreatment prognostic factors in carcinoma of the uterine cervix: A multivariable analysis of the effect of age, stage, histology and blood counts on survivalInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1983